The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Overview of Market Growth

• The chimeric antigen receptor T (CAR-T) cells market has experienced exponential growth.
• Market size increased from $2.76 billion in 2023 to $3.89 billion in 2024, at a CAGR of 40.9%.
• Forecasted growth to $14.35 billion in 2028, with a CAGR of 38.5%.

Drivers of Growth

• Breakthrough FDA approvals and successful clinical trials.
• Advances in gene editing techniques.
• Growing investment from pharmaceutical companies.
• Rising cancer incidence globally.

Rising Cancer Occurrence Drives Growth

• Cancer’s prevalence is a key driver for the CAR-T cells market.
• CAR-T cells used in treating various cancers including hematological malignancies and solid tumors.
• Global cancer cases expected to reach 1.9 million in 2021, with projected increases by 2040.
• Market players include Novartis International AG, Pfizer Inc., Kite Pharma, among others.

Read More On The Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2024 – https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report

Innovative Product Developments

• Product innovation is a significant trend.
• Companies focus on creating novel CAR-T cell-based treatments.
• Novartis AG launched the T-Charge CAR-T platform in December 2021.
• Major players driving innovation in the market.

Laurus Labs’ Strategic Acquisition

• Laurus Labs acquired a minority stake in Immunoadoptive Cell Therapy in November 2021.
• Strengthening biologics business and gaining access to emerging research areas.
• Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.

Market Segmentation

• By Target Antigen: CD19, CD22, Other Antigens.
• By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Others.
• By End User: Hospitals, Cancer Research Centres, Clinics.

Regional Insights

• North America led the CAR-T cells market in 2023.

Future Outlook

• Forecasted market growth attributed to regulatory streamlining and market expansion in emerging economies.
• Major trends include off-the-shelf CAR-T therapies and combination therapies.
• Technological advancements and focus on long-term safety and efficacy driving market evolution.

Conclusion

• The CAR-T cells market is witnessing remarkable growth, driven by factors such as rising cancer incidence and technological advancements.
• Innovations in product development and strategic acquisitions are shaping the market landscape.
• With continued research and development, the CAR-T cells market is poised for significant expansion in the coming years.

Request for A Sample Of The Global Chimeric Antigen Receptor T (CAR-T) Cells Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8124&type=smp